A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Interaction of PM2.5 Levels and Corticosteroid Administration on Cardiovascular and Thromboembolic Outcomes in Elderly Individuals

  • By

  • Shu-Ping Huang

  • Chien-Chou Su

  • Rachel Nethery

  • Kevin Josey

  • Benjamin Bates

  • David Robinson

  • Poonam Gandhi

  • Melanie Rua

  • Ashwaghosha Parthasarathi

  • Soko Setoguchi

  • Yea-huei Kao Yang

  • July 1, 2026

Share

Original Source(s)

A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults

  • by Shu-Ping Huang, Chien-Chou Su, Rachel Nethery, Kevin Josey, Benjamin Bates, David Robinson, Poonam Gandhi, Melanie Rua, Ashwaghosha Parthasarathi, Soko Setoguchi, Yea-huei Kao Yang

  • July 1, 2026

Related Content

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

Integrated management of atrial fibrillation and comorbidities in the community: a generalist-specialist collaborative RCT and subgroup analysis

Atrial fibrillation burden and oral anticoagulation: a context-dependent framework for net clinical benefit beyond binary AF definitions